跳至主要内容
临床试验/JPRN-jRCT1031210714
JPRN-jRCT1031210714招募中未知

A Multicenter Study Aiming to Clarify the Prevalence and Clinical Implications of ATTR Cardiac Amyloidosis in Patients with Heart Failure with Preserved/Mid-range Ejection Fraction - UNVEIL-ATTR-CA

Matsue Yuya0 个研究点目标入组 500 人开始时间: 2022年3月31日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 70age old 至 < 90age old(—)
性别
All

入选标准

  • i)Age >= 70 years old and < 90 years old
  • ii)Admitted under the diagnosis of heart failure based on Framingham criteria
  • iii)Left ventricular ejection fraction measured by echocardiography or CMR is >=40%
  • iv)Maximal left ventricular wall thickness >10 mm by echocardiography or CMR performed within 3 months
  • v)Those who have obtained written consent for participation in the study

排除标准

  • i)Amyloid has been already proven histologically
  • ii)Any cardiac surgery or major chest trauma within 4 weeks of index visit
  • iii)Treatment of heart failure with intravenous drugs
  • iv)History of myocardial infarction, and history of coronary artery disease needed coronary artery revascularization, including PCI/CABG within 6 months
  • v)Uncontrolled infection, or active malignancy, except for adequately treated basal cell carcinoma, squamous cell carcinoma of the skin, or in situ cervical cancer
  • vi)Received or planned liver transplant or heart transplant

研究者

发起方
Matsue Yuya

相似试验

已完成
不适用
Pulmonary Hypertension in the Intensive Care Unit (ICU) - Swiss Survey 1Pulmonary hypertensionHypertension
ISRCTN01751283Swiss Society of Pulmonary Hypertension (Switzerland)1,000
进行中(未招募)
1 期
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-BEActelion Pharmaceuticals Ltd.200
进行中(未招募)
1 期
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.Clostridium difficile-associated diarrhea (CDAD)MedDRA version: 20.0Level: LLTClassification code 10012734Term: Diarrhea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10054236Term: Clostridium difficile infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10022661Term: Intestinal infection due to clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10012748Term: Diarrhoea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestations
EUCTR2015-004805-17-ESActelion Pharmaceuticals Ltd.1
进行中(未招募)
1 期
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-ITActelion Pharmaceuticals Ltd.200
进行中(未招募)
1 期
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-HUActelion Pharmaceuticals Ltd.200
A Multicenter Study Aiming to Clarify the Prevalence... | 临床试验